Literature DB >> 124197

Editorial: side effects of practolol.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 124197      PMCID: PMC1673478     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  10 in total

1.  Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue.

Authors:  H E Amos; W D Brigden; R A McKerron
Journal:  Br Med J       Date:  1975-03-15

2.  Untoward effects associated with practolol administration: oculomucocutaneous syndrome.

Authors:  P Wright
Journal:  Br Med J       Date:  1975-03-15

3.  Fibrinous peritonitis: a complication of practolol therapy.

Authors:  W O Windsor; F Durrein; N H Dyer
Journal:  Br Med J       Date:  1975-04-12

4.  The value of patch and other skin tests in drug eruptions.

Authors:  R H Felix; J S Comaish
Journal:  Lancet       Date:  1974-05-25       Impact factor: 79.321

5.  Exfoliative dermatitis and practolol.

Authors:  M G Rowland; C J Stevenson
Journal:  Lancet       Date:  1972-05-20       Impact factor: 79.321

Review 6.  Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity.

Authors:  A C Allison; A M Denman; R D Barnes
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

7.  Significance of anti-D.N.A. antibodies in systemic lupus erythematosus.

Authors:  G R Hughes
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

8.  Cutaneous and ocular reactions to practolol.

Authors:  R H Felix; F A Ive; M G Dahl
Journal:  Br Med J       Date:  1974-11-09

9.  Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).

Authors:  P Brown; H Baddeley; A E Read; J D Davies; J McGarry
Journal:  Lancet       Date:  1974-12-21       Impact factor: 79.321

10.  Systemic lupus erythematosus syndrome induced by practolol.

Authors:  E B Raftery; A M Denman
Journal:  Br Med J       Date:  1973-05-26
  10 in total
  2 in total

1.  Effect in bronchial asthma of a new beta-adrenergic blocking drug atenolol (ICI 66, 082).

Authors:  N P Boye; J R Vale
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

2.  Influence of pindolol (Visken) on respiratory function in 20 asthmatic patients.

Authors:  C C Christensen; N P Boye; H Erikson; G Hansen
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.